Delcath Systems, Inc. (DCTH)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.96 |
| Open | 7.05 |
| Bid | 7.52 x 500 |
| Ask | 7.59 x 400 |
| Day's range | 7.00 - 7.71 |
| 52-week range | 2.25 - 7.99 |
| Volume | |
| Avg. volume | 251,527 |
| Market cap | 210.339M |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.94 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.83 |
- GuruFocus.com
Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
Explore Delcath Systems Inc's robust Q1 2024 performance, featuring significant revenue growth, operational expansions, and strategic insights into future profitability.
PR NewswireDelcath Systems Reports First Quarter 2024 Results and Business Highlights
Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial results and business highlights for the first quarter ended March 31, 2024.
- PR Newswire
Delcath Systems to Host First Quarter 2024 Earnings Call
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2024.
© 2024 Yahoo. All rights reserved.